Document Details
Form
Filing Date
Mar 20, 2024
Document Date
Mar 18, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
UroGen Pharma, Ltd
Issuer
UroGen Pharma Ltd.
Filer
Schoenberg Mark